updat model reflect management revis guidanc well outlook
beyond estimate flat adj ep growth although management expect
oper improv beyond estimate mid-singl digit growth
depend execut long-term strategi leverag partnership
digit drive growth profit
tradit offset reimburs pressur
updat model reflect management updat guidanc roughli flat
constant currenc basi along foreign currenc headwind
lower adj ep estim signific driver
downward revis adj ep estim greater gross margin degrad
retail usa previou assumpt bp bp primarili due
diminish contribut tradit offset reimburs pressur
lower gener util also lower retail usa revenu estim
reimburs affect top line said lower sg expens retail usa due
lower bonu accrual lower tax rate greater share repo partial off-set neg
impact gross margin deterior retail usa
adj ep estim flat line management expect
management expect adj ep flat despit expect improv oper
perform retail usa due bonu accrual without bonu accrual management estim
adj ep would mid-singl digit growth retail usa expect improv
volum due partnership digit effort ramp certain medicar
part contract estim modest improv pharmaci same-stor
sale comp estim greater improv front-end same-stor sale
pharmaci due diminish impact deemphas tobacco assum
gross margin degrad deceler bp
gener util improv greater medicar part volum
advers affect due onboard fep contract note still expect
consider gross margin headwind macro trend indic reimburs
pressur like persist adj sg declin due on-going transform
manag program partial off-set bonu accrual
updat model estim adj ep growth toward
lower end management mid- high-singl digit long-term guidanc outer year adj
ep growth rate depend upon management execut long-term strategi
leverag partnership digit drive growth profit
assum acceler top-lin growth moder gross margin degrad well
benefit continu improv sg expect revenu growth acceler
partnership ramp also expect moder gross margin degrad
assum sg improv due management transform manag program
although signific portion save expect deploy invest
partnership digit effort
pleas see page report import disclosur
market perform rate think compani weakli posit
transit toward value-bas care rel peer other pharma
suppli chain manag care industri consolid integr medic
pharmaci data stand still reliant tradit retail pharmaci
model believ leav expos potenti disrupt also
think ownership acquisit aet rather partnership open health
hub necessari realiz benefit cost trend improv without
see potenti margin distribut channel greater risk
disrupt furthermor manag consist meet exceed adj ep
estim fare well base oper metric think indic
challeng macro environ
y/i top-lin growth driven
growth part acquisit
alliancerx includ fep contract
margin pressur continu
share repo
y/i top-lin growth high-singl
lower expect margin pressur
share repo greater
benefit disrupt cvs/aet
greater expect margin pressur
walgreen oper largest drugstor chain compani sell product
servic retail drugstor mail telephon on-line
channel within store walgreen sell prescript non-prescript drug
well gener merchandis includ household item conveni fresh food
person care beauti care photo finish candi primarili within retail locat
walgreen oper take clinic walgreen also oper specialti infus
respiratori servic mail servic
lower adj ep estim
respect also lower price target base revis
dcf analysi impli share trade adj ep estim
million except per-shar data
cowen compani
model assumptionstermin growth tax depreci chang work terminal- capit valuefre pv npv free npv futur excess valu total number valu per year end august cowen
million except per-shar data
compani report cowen compani
fifo cost fifo gross fifo gross chang lifo lifo gross lifo gross equiti earn ab- adjust equiti earn adjust oper adjust oper expens pre-tax pre-tax tax incom tax tax earn equiti method net earn non-controlling adjust net total net averag dilut adjust chang gross gross oper year end august cowen
million except per-shar data
compani report cowen compani
fifo cost fifo gross fifo gross chang lifo lifo gross lifo gross equiti earn ab- adjust equiti earn adjust oper adjust oper expens pre-tax pre-tax tax report incom tax incom tax tax earn equiti method net earn non-controlling adjust net total net averag dilut adjust chang gross gross oper cowen
million
compani report cowen compani
asset cash account receiv current current properti intang non-curr total current liabil short-term trade account accru expens incom current long-term defer incom non-curr stockhold equiti common paid-in employe stock loan retain accumul comprehens treasuri non-controlling total stockhold total liabil stockhold short-term liquid ratio current sale purchas acct ratio inventori structur long-term solvenc ratio total debt total interest ratio return invest capit averag total asset averag stockhold equiti year end august cowen
million
compani report cowen compani
income/ loss flow oper activ depreci gain previous held equiti interest- share base compens unreal gain fair valu adjustments- defer incom invest impair chang oper asset liabil receiv current non-curr account accru expens incom non-curr net cash oper acquisit properti acquisit issuanc common purchas treasuri dividend proceeds/ purchas secur proceeds/ repay debt net increase/ decreas cash equival begin cash equival end cowen summari oper capit owner financ non-recur exclud non-recur itemsfor year end august cowen
million
compani report cowen compani
flow oper activ net adjust reconcil net earn net cash depreci loss allianc boot call sale business- defer incom stock compens incom tax save employe stock plans- chang oper asset liabil account receiv current trade account accru expens incom non-curr asset net cash provid oper flow invest activitiesaddit properti proce sale leaseback transactions- purchas short-term invest held proce short-term invest held purchas short-term invest avail sale- proce sale short-term invest avail sale- return invest restrict cash- proce sale busi intang asset acquisit net cash payment proce sale invest invest allianc boots- net cash use invest flow financ activitiesnet payment short-term borrowings- payment long-term proce financ issuanc long-term debt- stock proce relat employe stock dividend net cash provid use financ effect exchang rate chang cash cash equivalents- chang equivalentsnet decreas cash cash cash equival begin cash equival end year end august cowen
use five-year discount cash flow analysi primari valuat method
deriv price target gener assum discount rate may appli
appropri adjust depend compani and/or industri specif factor also
assum termin growth rate depend long-term view specif
sub-industri coverag note discount rate assumpt could view
conserv rel actual weight averag cost capit view
assumpt reason long run lower discount rate assumpt
increas termin growth rate assumpt would lead higher estim valu
per share secondari measur look forward price-to-earnings multipl ev/sal ratio
impli dcf analysi compar histor averag
see number risk associ drug retail space industri highli
competit retail drugstor chain independ pharmaci mail-ord provid
well retail includ groceri store mass merchant warehous club on-line
store compet space could pressur front-end sale margin
current wave drug patent expir posit impact profit
deriv gener expect taper significantli next sever year
specialti provid signific tailwind part believ
could concern around sustain high growth area
believ impact ppaca expect increas volum could subdu
depend implement execut
number company-specif risk associ pt includ loss
share disrupt entiti wors expect reimburs pressur better
expect gener procur wbad meaning acquisit
author research report herebi certifi view express research report accur reflect person view subject
secur issuer ii part compens relat directli indirectli specif recommend view express report
